Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
16 417 NOK
20 315 NOK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
13 758 NOK
14 970 NOK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
- NOK
- NOK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
357,000 NOK
442,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.